
|Articles|April 1, 2002
Corticosteroid foam moves beyond scalp psoriasis
Maui, Hawaii - Already FDA-approved for scalp psoriasis, clobetasol propionate foam is effective against mild to moderate psoriasis in other parts of the body as well.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Top 5 Articles of the Week: November 30-December 5
3
The Weekly Roundup: December 1-5
4
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
5



















